The Peripheral T-Cell Lymphomas. Группа авторов
23 Allogeneic Stem‐cell Transplantation Introduction Allogeneic Stem‐cell Transplantation for Relapsed and Refractory Disease (Focus on Nodal Hystotypes) Allogeneic Stem‐cell Transplantation as Consolidation of First Remission Allogeneic Stem‐cell Transplantation in Specific Subtypes Future Directions Must Reads References 24 Emerging Immunotherapy Approaches in Peripheral T‐cell Lymphomas Introduction Monoclonal Antibody Therapy Immunoconjugate‐Based Therapy for Peripheral T‐Cell Lymphoma Cell‐Mediated or Cellular Immunotherapy in Peripheral T‐Cell Lymphoma Challenges and Future Directions Must Reads References 25 Emerging New Small Molecules in Peripheral T‐cell Lymphomas Introduction Demethylating Agents Janus‐associated Kinase–Signal Transducers and Activators of Transcription and Spleen Tyrosine Kinase Inhibitors Phosphatidylinositol 3‐Kinase Inhibitors Miscellaneous Conclusion Must Reads References
10 Part V: Future Directions 26 The Value and Relevance of T‐cell Lymphoma Registries Introduction Population‐based Cancer Registries Retrospective Studies T‐cell Lymphoma Registries Future Directions Disclosures Must Reads References 27 Innovative Chemotherapy‐free Approaches for the Treatment of Peripheral T‐Cell Lymphoma Introduction Targeting the Peripheral T‐cell Lymphoma Epigenome Romidepsin Plus Pralatrexate Romidepsin Plus 5‐Azacytidine Romidepsin Plus Duvelisib Romidepsin Plus Lenalidomide Panobinostat and Bortezomib A Glance at the Future: Building on the Active Doublets Must Reads References 28 Global Collaborations Introduction The Global T‐cell Lymphoma Consortium Conclusion
11 Index
List of Tables
1 Chapter 2Table 2.1 Main nodal and extranodal mature T‐cell neoplasms with summary of t...
2 Chapter 3Table 3.1 Classes of histone deacetylase inhibitor (HDACi).Table 3.2 Single agents targeting the T‐cell lymphoma epigenome.Table 3.3 Combination agents targeting the T‐cell lymphoma epigenome.
3 Chapter 4Table 4.1 Mouse models of peripheral T‐cell lymphomas (PTCL)
4 Chapter 5Table 5.1 Major lymphoma subtypes by geographic region
5 Chapter 8Table 8.1 Peripheral T‐cell lymphoma not otherwise specified molecular subgroup...
6 Chapter 9Table 9.1 Characteristic of patients with angioimmunoblastic T‐cell lymphoma ...Table 9.2 Frequency of mutations of genes implicated in DNA methylation in an...
7 Chapter 10Table 10.1 Clinical features of anaplastic large‐cell lymphomas.Table 10.2 Pathological and molecular features of anaplastic large‐cell lymph...Table 10.3 Current treatment of anaplastic large‐cell lymphoma.Table 10.4 Future directions for treatment of anaplastic large‐cell lymphoma.
8 Chapter 11Table 11.1 Prospective clinical trials for aggressive adult T‐cell leukemia/l...Table 11.2 Meta‐analysis of interferon alpha plus zidovudine for adult T‐cell...
9 Chapter 12Table 12.1 Chemoradiotherapy regimens for stage IE/IIE nasal extranodal natur...
10 Chapter 13Table 13.1 Outcomes of stem‐cell transplants in published patient series.
11 Chapter 14Table 14.1 Current treatments in large granular lymphocyte leukemia [1, 3].Table 14.2 The future of treatment in large granular lymphocyte leukemia.
12 Chapter 17Table 17.1 Association of hepatosplenic T‐cell lymphoma and immunosuppression...Table 17.2 Summary of outcomes in case series of hepatosplenic T‐cell lymphom...
13 Chapter